1 |
Bagan J, Sarrion G, Jimenez Y. Oral cancer: clinical features[J]. Oral Oncol, 2010, 46(6): 414-417.
|
2 |
Markopoulos AK. Current aspects on oral squamous cell carcinoma[J]. Open Dent J, 2012, 6: 126-130.
|
3 |
Ganly I, Yang LY, Giese RA, et al. Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus[J]. Int J Cancer, 2019, 145(3): 775-784.
|
4 |
Chocolatewala N, Chaturvedi P, Desale R. The role of bacteria in oral cancer[J]. Indian J Med Paediatr Oncol, 2010, 31(4): 126-131.
|
5 |
Katz J, Onate MD, Pauley KM, et al. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma[J]. Int J Oral Sci, 2011, 3(4): 209-215.
|
6 |
Fitzsimonds ZR, Rodriguez-Hernandez CJ, Bagaitkar J, et al. From beyond the pale to the pale riders: the emerging association of bacteria with oral cancer[J]. J Dent Res, 2020, 99(6): 604-612.
|
7 |
Schwaller B. The continuing disappearance of “pure” Ca2+ buffers[J]. Cell Mol Life Sci, 2009, 66(2): 275-300.
|
8 |
Liu Y, Porta A, Peng X, et al. Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k[J]. J Bone Miner Res, 2004, 19(3): 479-
|
490 |
|
9 |
Bellido T, Huening M, Raval-Pandya M, et al. Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity[J]. J Biol Chem, 2000, 275(34): 26328-26332.
|
10 |
Sun S, Li F, Gao X, et al. Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway[J]. Neuroscience, 2011, 199: 359-367.
|
11 |
Jin CJ, Lin T, Shan LQ. Downregulation of calbindin 1 by miR-454-3p suppresses cell proliferation in nonsmall cell lung cancer in vitro[J]. Cancer Biother Radiopharm, 2019, 34(2): 119-127.
|
12 |
Cao LQ, Wang YN, Liang M, et al. CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells[J]. Mol Med Rep, 2019, 19(6): 5097-5104.
|
13 |
Huang ZX, Fan GJ, Wang DL. Downregulation of calbindin 1, a calcium-binding protein, reduces the proliferation of osteosarcoma cells[J]. Oncol Lett, 2017, 13(5): 3727-3733.
|
14 |
Yang XY, Wang Y, Pang SL, et al. LINC00665 promotes the progression of acute myeloid leukemia by regulating the miR-4458/DOCK1 pathway[J]. Sci Rep, 2021, 11(1): 5009.
|
15 |
García-Cano J, Sánchez-Tena S, Sala-Gaston J, et al. Re-gulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2[J]. Mol Oncol, 2020, 14(1): 69-86.
|
16 |
Jeon MH, Jeon CJ. Immunocytochemical localization of calretinin containing neurons in retina from rabbit, cat, and dog[J]. Neurosci Res, 1998, 32(1): 75-84.
|
17 |
Ozmen O, Topsakal S. Examination of skin lesions in rats with induced hyperthyroidism and hypothyroidism[J]. Biotech Histochem, 2020, 95(6): 438-444.
|
18 |
Korkmaz Y, Klinz FJ, Beikler T, et al. The Ca2+-binding protein calretinin is selectively enriched in a subpopulation of the epithelial rests of Malassez[J]. Cell Tissue Res, 2010, 342(3): 391-400.
|
19 |
Coleman H, Altini M, Ali H, et al. Use of calretinin in the differential diagnosis of unicystic ameloblastomas[J]. Histopathology, 2001, 38(4): 312-317.
|
20 |
Dorien FO, Roskams T, van den Eynde K, et al. The presence of endometrial cells in peritoneal fluid of women with and without endometriosis[J]. Reprod Sci, 2017, 24(2): 242-251.
|
21 |
Passebosc-Faure K, Li GR, Lambert C, et al. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions[J]. Clin Cancer Res, 2005, 11(19Pt 1): 6862-6867.
|
22 |
Ohshima J, Wang Q, Fitzsimonds ZR, et al. Streptococcus gordonii programs epithelial cells to resist ZEB2 induction by Porphyromonas gingivalis[J]. Proc Natl Acad Sci U S A, 2019, 116(17): 8544-8553.
|
23 |
Arif SH. A Ca2+-binding protein with numerous roles and uses: parvalbumin in molecular biology and physiology[J]. Bioessays, 2009, 31(4): 410-421.
|
24 |
Tang X, Asano M, O'Reilly A, et al. P53 is an important regulator of CCL2 gene expression[J]. Curr Mol Med, 2012, 12(8): 929-943.
|
25 |
Kuboniwa M, Hasegawa Y, Mao S, et al. P. gingivalis accelerates gingival epithelial cell progression through the cell cycle[J]. Microbes Infect, 2008, 10(2): 122-128.
|
26 |
鲁泽, 潘亚萍. 牙龈卟啉单胞菌促进口腔鳞状细胞癌发生机制研究进展 [J]. 中国实用口腔科杂志, 2019, 12(10): 617-621.
|
|
Lu Z, Pan YP. Research progress in the mechanism of Porphyromonas gingivalis in promoting oral squamous cell cancer[J]. Chin J Pract Stomatol, 2019, 12(10): 617-
|
621 |
|
27 |
Vousden KH. Outcomes of p53 activation—spoilt for choice[J]. J Cell Sci, 2006, 119(Pt 24): 5015-5020.
|
28 |
Oliner JD, Pietenpol JA, Thiagalingam S, et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53[J]. Nature, 1993, 362(6423): 857-860.
|